MARATHON CAPITAL MANAGEMENT

Position in DYAI — Dyadic International Inc

CIK 1213206 Hunt Valley, MD

Position in DYAI

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$99,000

+$8,800 QoQ

Shares Held

110,000

0.0% QoQ

Ownership

0.302%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 39 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MARATHON CAPITAL MANAGEMENT holds $5,159,453 across 4 Biotechnology names. DYAI ranks #3 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADMA	Adma Biologics, Inc.	532,353	$4,455,794
2	RPRX	Royalty Pharma plc	9,364	$525,039
3	DYAI	Dyadic International Inc This page	110,000	$99,000
4	RXRX	Recursion Pharmaceuticals, Inc.	21,695	$79,620

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$99,000	110,000	0.0%	Shares	Sole	2026-07-22
2026-03-31	$90,200	110,000	+29.4%	Shares	Sole	2026-05-14
2025-12-31	$79,900	85,000	+142.9%	Shares	Sole	2026-01-29
2025-09-30	$41,300	35,000	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.